---
title: The Study of EIT-guided Ventilation Strategy on ARDS Patients
nct_id: NCT04734340
overall_status: UNKNOWN
phase: NA
sponsor: Peking Union Medical College Hospital
study_type: INTERVENTIONAL
primary_condition: ARDS
countries: China
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT04734340.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT04734340"
ct_last_update_post_date: 2021-02-02
last_seen_at: "2026-05-12T06:50:20.613Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# The Study of EIT-guided Ventilation Strategy on ARDS Patients

**NCT ID:** [NCT04734340](https://clinicaltrials.gov/study/NCT04734340)

## Key Facts

- **Status:** UNKNOWN
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 100
- **Lead Sponsor:** Peking Union Medical College Hospital
- **Conditions:** ARDS, Pulmonary Perfusion
- **Start Date:** 2021-01-01
- **Completion Date:** 2023-06-01
- **CT.gov Last Update:** 2021-02-02

## Brief Summary

This study is a clinical randomized controlled study.The objective of this study is to compare the prognosis of patients with ARDS between eit-v / q-oriented individualized ventilation strategy and traditional lung protection ventilation strategy, and to establish the demonstration application of eit-v / q-oriented ventilation strategy in ARDS

## Eligibility

- **Minimum age:** 18 Years
- **Maximum age:** 80 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

1. According to ARDS Berlin standard, ARDS, PaO2 / FiO2 \< 200mmhg, peep \> 5cmh2o;
2. According to clinical judgment, lung recruitment therapy is needed due to hypoxemia;
3. The subjects or their families signed informed consent.
4. Admission to ICU was less than 72 hours;
5. The estimated duration of mechanical ventilation was more than or equal to 48 hours;
6. Age ≥ 18 years old and ≤ 80 years old;

Exclusion Criteria:

1. The patients with heart implants could not be monitored by EIT;
2. Patients or their families refused to participate in the study;
3. Hypernatremia
```

## Arms

- **EIT-guided group** (EXPERIMENTAL) — Treatment based on EIT
- **Control group** (PLACEBO_COMPARATOR) — Treatment based on ARDS-net Peep setting

## Interventions

- **EIT-guided PEEP setting** (PROCEDURE) — Ventilator parameter setting by EIT
- **ARDS-net PEEP setting** (PROCEDURE) — Ventilator parameter setting according to ARDS-net table

## Primary Outcomes

- **ventilation free days** _(time frame: 1 Day)_

## Secondary Outcomes

- **28-day mortality** _(time frame: 28 days)_

## Locations (1)

- Peking Union Medical College Hospital, Beijing, Beijing Municipality, China — _RECRUITING_

## Recent Field Changes (last 30 days)

- `outcomes.primary` — added _(2026-05-12)_
- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.peking union medical college hospital|beijing|beijing municipality|china` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT04734340.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT04734340*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*